2/2
09:01 am
dgx
Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease [Yahoo! Finance]
Low
Report
Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease [Yahoo! Finance]
2/2
08:52 am
dgx
Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease
Low
Report
Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease
1/30
07:00 am
dgx
Quest Diagnostics (NYSE:DGX) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $210.00 price target on the stock.
Low
Report
Quest Diagnostics (NYSE:DGX) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $210.00 price target on the stock.
1/25
03:05 am
dgx
Quest Diagnostics (NYSE:DGX) was downgraded by analysts at
Wall Street Ze
Low
Report
Quest Diagnostics (NYSE:DGX) was downgraded by analysts at
Wall Street Ze
1/21
03:03 pm
dgx
Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year [Yahoo! Finance]
Low
Report
Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year [Yahoo! Finance]
1/21
02:35 pm
dgx
Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year
Low
Report
Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year
1/15
09:00 am
dgx
Sonora Quest and Laboratory Sciences of Arizona Announce Jennifer Erickson as CEO-Elect
Low
Report
Sonora Quest and Laboratory Sciences of Arizona Announce Jennifer Erickson as CEO-Elect
1/8
10:00 am
dgx
Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026
Low
Report
Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026
1/8
09:57 am
dgx
Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs [Yahoo! Finance]
Low
Report
Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs [Yahoo! Finance]
1/6
10:14 am
dgx
Data Featuring Haystack MRD® from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium [Yahoo! Finance]
Low
Report
Data Featuring Haystack MRD® from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium [Yahoo! Finance]
1/6
10:01 am
dgx
Data Featuring Haystack MRD® from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium
Low
Report
Data Featuring Haystack MRD® from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium
1/6
09:27 am
dgx
PracticeQ Partners With Fullscript to Streamline Lab Testing and Improve Patient Care [Yahoo! Finance]
Medium
Report
PracticeQ Partners With Fullscript to Streamline Lab Testing and Improve Patient Care [Yahoo! Finance]
1/5
09:54 am
dgx
What You Need To Know Ahead of Quest Diagnostics' Earnings Release [Yahoo! Finance]
Low
Report
What You Need To Know Ahead of Quest Diagnostics' Earnings Release [Yahoo! Finance]
1/5
09:04 am
dgx
Corewell Health and Quest Diagnostics Complete Laboratory Joint Venture Transaction in Michigan [Yahoo! Finance]
Low
Report
Corewell Health and Quest Diagnostics Complete Laboratory Joint Venture Transaction in Michigan [Yahoo! Finance]
1/5
08:58 am
dgx
Corewell Health and Quest Diagnostics Complete Laboratory Joint Venture Transaction in Michigan
Low
Report
Corewell Health and Quest Diagnostics Complete Laboratory Joint Venture Transaction in Michigan
1/5
02:21 am
dgx
Quick Fix Synthetic Highlights Temperature as Leading Cause of Invalid Urine Samples in 2026 [Yahoo! Finance]
Low
Report
Quick Fix Synthetic Highlights Temperature as Leading Cause of Invalid Urine Samples in 2026 [Yahoo! Finance]
1/2
11:05 am
dgx
Q3 Earnings Highlights: Quest (NYSE:DGX) Vs The Rest Of The Testing & Diagnostics Services Stocks [Yahoo! Finance]
Low
Report
Q3 Earnings Highlights: Quest (NYSE:DGX) Vs The Rest Of The Testing & Diagnostics Services Stocks [Yahoo! Finance]
12/30
04:14 pm
dgx
Quest Diagnostics (NYSE:DGX) had its "buy (b-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Quest Diagnostics (NYSE:DGX) had its "buy (b-)" rating reaffirmed by analysts at
Weiss Ratings.
12/25
11:31 pm
dgx
????????????????????????????????????????? [CNET News]
Low
Report
????????????????????????????????????????? [CNET News]
12/19
04:05 pm
dgx
Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/19
03:20 pm
dgx
Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference
12/15
11:12 am
dgx
Quest Diagnostics Stock: Is DGX Outperforming the Healthcare Sector? [Yahoo! Finance]
Low
Report
Quest Diagnostics Stock: Is DGX Outperforming the Healthcare Sector? [Yahoo! Finance]
12/11
09:13 am
dgx
Rare Disease Genetic Testing Market to Reach USD 3.79 Billion by 2032 | Growth is Driven by Rising Demand for Early Diagnostic Solutions Globally – SNS Insider [Yahoo! Finance]
Low
Report
Rare Disease Genetic Testing Market to Reach USD 3.79 Billion by 2032 | Growth is Driven by Rising Demand for Early Diagnostic Solutions Globally – SNS Insider [Yahoo! Finance]
12/1
08:41 am
dgx
Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States [Yahoo! Finance]
Low
Report
Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States [Yahoo! Finance]
12/1
08:30 am
dgx
Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States
Low
Report
Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States